Expert Interview
Discussing investigational agents in mCRPC including VIR-5500, JANX007 and xaluritamig (anti-STEAP)
Ticker(s): VIR, AMGN, JANXInstitution: John Hopkins
- Co-director of the Johns Hopkins prostate multidisciplinary clinic. Shenderov Lab focuses on the elucidation of the mechanisms of immune response and resistance to immunotherapy in Prostate Cancer.
- Manage/consult on 25-50 prostate cancer patients per month.
- Familiar with investigational agents in mCRPC
What is your opinion of VIR-5500?
Added By: wilson_adminWhat is your opinion of JANX007?
Added By: wilson_adminWhat is your opinion of xaluritamig (anti-STEAP)?
Added By: wilson_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
